⚠ Disclaimer: This report is generated using AI tools and is for informational purposes only. It does not constitute investment advice. Please consult a registered financial advisor before making any investment decisions.

CLEAN - Fundamental Analysis: Financial Health & Valuation

Back to List

Rating: 3.8

Last Updated Time : 02 Feb 26, 01:08 pm

Fundamental Rating: 3.8

Stock Code CLEAN Market Cap 8,590 Cr. Current Price 808 ₹ High / Low 1,600 ₹
Stock P/E 31.6 Book Value 146 ₹ Dividend Yield 0.74 % ROCE 29.3 %
ROE 21.9 % Face Value 1.00 ₹ DMA 50 894 ₹ DMA 200 1,085 ₹
Chg in FII Hold -1.13 % Chg in DII Hold 0.79 % PAT Qtr 51.9 Cr. PAT Prev Qtr 64.6 Cr.
RSI 31.7 MACD -13.2 Volume 7,38,419 Avg Vol 1Wk 3,95,194
Low price 801 ₹ High price 1,600 ₹ PEG Ratio 3.70 Debt to equity 0.00
52w Index 0.88 % Qtr Profit Var -30.0 % EPS 25.6 ₹ Industry PE 26.3

📊 Financials: Clean Science and Technology Ltd. has reported PAT of 51.9 Cr compared to 64.6 Cr previously, reflecting a -30% quarterly profit variation. ROE at 21.9% and ROCE at 29.3% highlight strong efficiency. Debt-to-equity ratio of 0.00 indicates a debt-free balance sheet, strengthening financial stability. EPS of 25.6 ₹ supports earnings visibility, though profit momentum has weakened.

💹 Valuation: Current P/E of 31.6 is above the industry average (26.3), suggesting premium valuation. P/B ratio ~5.53 (Price 808 ₹ / Book Value 146 ₹) is expensive relative to book value. PEG ratio of 3.70 indicates stretched valuation compared to growth. Dividend yield of 0.74% provides modest income support. Intrinsic value appears lower than current price, reflecting overvaluation.

🏢 Business Model: Clean Science operates in specialty chemicals, focusing on green chemistry and sustainable manufacturing processes. Competitive advantage lies in niche product portfolio, strong R&D, and global customer base. The company benefits from rising demand for eco-friendly chemicals and exports.

📈 Entry Zone: Attractive accumulation zone between 780–800 ₹, near its 52-week low (801 ₹) and below DMA200 (1,085 ₹). RSI at 31.7 indicates oversold conditions, while MACD (-13.2) suggests bearish momentum. Long-term investors can accumulate cautiously at lower levels.

🔒 Holding Guidance: Fundamentally strong with debt-free operations and high efficiency metrics. However, valuations are stretched and profit momentum has slowed. Suitable for long-term holding only if accumulated near support levels for margin of safety.


Positive

  • Debt-free balance sheet enhances financial resilience.
  • Strong ROE (21.9%) and ROCE (29.3%) highlight efficiency.
  • Niche positioning in specialty chemicals with global demand.
  • DII holdings increased (+0.79%), reflecting domestic confidence.

Limitation

  • Quarterly PAT decline (-30%) raises caution on earnings momentum.
  • High P/E (31.6) compared to industry average (26.3).
  • P/B ratio of 5.53 indicates expensive valuation.
  • PEG ratio of 3.70 highlights stretched valuation relative to growth.
  • FII holdings decreased (-1.13%), showing foreign caution.

Company Negative News

  • No major negative news reported, but profit decline and reduced FII holdings raise caution.

Company Positive News

  • Debt-free operations strengthen balance sheet stability.
  • Strong efficiency metrics with high ROE and ROCE.
  • Global demand for eco-friendly specialty chemicals supports long-term growth.

Industry

  • Specialty chemicals sector benefits from rising global demand and sustainability trends.
  • Industry P/E at 26.3 suggests moderate optimism.
  • Export-driven demand provides long-term growth opportunities.

Conclusion

✅ Clean Science and Technology Ltd. is financially strong, debt-free, and efficient with niche positioning in specialty chemicals. However, valuations are stretched and profit momentum has slowed. Long-term investors may accumulate near 780–800 ₹ for margin of safety, while monitoring earnings growth and global demand trends.

I can also extend this with a peer comparison against Aarti Industries, Navin Fluorine, and SRF to highlight Clean Science’s relative valuation and efficiency. Would you like me to add that?

NIFTY 50 - Fundamental Stock Watchlist

NEXT 50 - Fundamental Stock Watchlist

MIDCAP - Fundamental Stock Watchlist

SMALLCAP - Fundamental Stock Watchlist